Product Description
protein sub-unit vaccine for Campylobacter Infection
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: Injection
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: TD Vaccines A/S
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Campylobacter Infections
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT00859716 |
ACE393-103VC | P2 |
Unknown status |
Campylobacter Infections |
2009-03-01 |
2019-03-18 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|